Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.

Identifieur interne : 000578 ( Main/Corpus ); précédent : 000577; suivant : 000579

Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.

Auteurs : Varun U. Shetty ; Brian Jason Brotherton ; Andrew Achilleos ; Kevan M. Akrami ; Lia M. Barros ; William Checkley ; Natalie Cobb ; Stephanie Maximous ; David Misango ; Casey Park ; Shaurya Taran ; Burton W. Lee ; For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand

Source :

RBID : pubmed:33377451

Abstract

The therapeutic options for COVID-19 patients are currently limited, but numerous randomized controlled trials are being completed, and many are on the way. For COVID-19 patients in low- and middle-income countries (LMICs), we recommend against using remdesivir outside of a clinical trial. We recommend against using hydroxychloroquine ± azithromycin or lopinavir-ritonavir. We suggest empiric antimicrobial treatment for likely coinfecting pathogens if an alternative infectious cause is likely. We suggest close monitoring without additional empiric antimicrobials if there are no clinical or laboratory signs of other infections. We recommend using oral or intravenous low-dose dexamethasone in adults with COVID-19 disease who require oxygen or mechanical ventilation. We recommend against using dexamethasone in patients with COVID-19 who do not require supplemental oxygen. We recommend using alternate equivalent doses of steroids in the event that dexamethasone is unavailable. We also recommend using low-dose corticosteroids in patients with refractory shock requiring vasopressor support. We recommend against the use of convalescent plasma and interleukin-6 inhibitors, such as tocilizumab, for the treatment of COVID-19 in LMICs outside of clinical trials.

DOI: 10.4269/ajtmh.20-1106
PubMed: 33377451
PubMed Central: PMC7957231

Links to Exploration step

pubmed:33377451

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.</title>
<author>
<name sortKey="Shetty, Varun U" sort="Shetty, Varun U" uniqKey="Shetty V" first="Varun U" last="Shetty">Varun U. Shetty</name>
<affiliation>
<nlm:affiliation>Critical Care Medicine Department, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brotherton, Brian Jason" sort="Brotherton, Brian Jason" uniqKey="Brotherton B" first="Brian Jason" last="Brotherton">Brian Jason Brotherton</name>
<affiliation>
<nlm:affiliation>Department of Internal Medicine, Kijabe Medical Center, Kijabe, Kenya.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Critical Care Medicine Department, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Achilleos, Andrew" sort="Achilleos, Andrew" uniqKey="Achilleos A" first="Andrew" last="Achilleos">Andrew Achilleos</name>
<affiliation>
<nlm:affiliation>Department of Critical Care, Sunnybrook Health Sciences Center, Toronto, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Akrami, Kevan M" sort="Akrami, Kevan M" uniqKey="Akrami K" first="Kevan M" last="Akrami">Kevan M. Akrami</name>
<affiliation>
<nlm:affiliation>Critical Care Medicine, University of California San Diego, San Diego, California.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Divisions of Infectious Disease, University of California San Diego, San Diego, California.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Barros, Lia M" sort="Barros, Lia M" uniqKey="Barros L" first="Lia M" last="Barros">Lia M. Barros</name>
<affiliation>
<nlm:affiliation>Department of Cardiology, University of Washington Medical Center, Seattle, Washington.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Checkley, William" sort="Checkley, William" uniqKey="Checkley W" first="William" last="Checkley">William Checkley</name>
<affiliation>
<nlm:affiliation>Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cobb, Natalie" sort="Cobb, Natalie" uniqKey="Cobb N" first="Natalie" last="Cobb">Natalie Cobb</name>
<affiliation>
<nlm:affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington Medical Center, Seattle, Washington.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maximous, Stephanie" sort="Maximous, Stephanie" uniqKey="Maximous S" first="Stephanie" last="Maximous">Stephanie Maximous</name>
<affiliation>
<nlm:affiliation>Division of Pulmonary Allergy Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Misango, David" sort="Misango, David" uniqKey="Misango D" first="David" last="Misango">David Misango</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesiology and Critical Care Medicine, Aga Khan University Hospital, Nairobi, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Park, Casey" sort="Park, Casey" uniqKey="Park C" first="Casey" last="Park">Casey Park</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Interdepartmental Division of Critical Care Medicine, Toronto, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taran, Shaurya" sort="Taran, Shaurya" uniqKey="Taran S" first="Shaurya" last="Taran">Shaurya Taran</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Interdepartmental Division of Critical Care Medicine, Toronto, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lee, Burton W" sort="Lee, Burton W" uniqKey="Lee B" first="Burton W" last="Lee">Burton W. Lee</name>
<affiliation>
<nlm:affiliation>Division of Pulmonary Allergy Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="For The Covid Lmic Task Force And The Mahidol Oxford Research Unit Moru Bangkok Thailand" sort="For The Covid Lmic Task Force And The Mahidol Oxford Research Unit Moru Bangkok Thailand" uniqKey="For The Covid Lmic Task Force And The Mahidol Oxford Research Unit Moru Bangkok Thailand" last="For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand">For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33377451</idno>
<idno type="pmid">33377451</idno>
<idno type="doi">10.4269/ajtmh.20-1106</idno>
<idno type="pmc">PMC7957231</idno>
<idno type="wicri:Area/Main/Corpus">000578</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000578</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.</title>
<author>
<name sortKey="Shetty, Varun U" sort="Shetty, Varun U" uniqKey="Shetty V" first="Varun U" last="Shetty">Varun U. Shetty</name>
<affiliation>
<nlm:affiliation>Critical Care Medicine Department, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Brotherton, Brian Jason" sort="Brotherton, Brian Jason" uniqKey="Brotherton B" first="Brian Jason" last="Brotherton">Brian Jason Brotherton</name>
<affiliation>
<nlm:affiliation>Department of Internal Medicine, Kijabe Medical Center, Kijabe, Kenya.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Critical Care Medicine Department, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Achilleos, Andrew" sort="Achilleos, Andrew" uniqKey="Achilleos A" first="Andrew" last="Achilleos">Andrew Achilleos</name>
<affiliation>
<nlm:affiliation>Department of Critical Care, Sunnybrook Health Sciences Center, Toronto, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Akrami, Kevan M" sort="Akrami, Kevan M" uniqKey="Akrami K" first="Kevan M" last="Akrami">Kevan M. Akrami</name>
<affiliation>
<nlm:affiliation>Critical Care Medicine, University of California San Diego, San Diego, California.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Divisions of Infectious Disease, University of California San Diego, San Diego, California.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Barros, Lia M" sort="Barros, Lia M" uniqKey="Barros L" first="Lia M" last="Barros">Lia M. Barros</name>
<affiliation>
<nlm:affiliation>Department of Cardiology, University of Washington Medical Center, Seattle, Washington.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Checkley, William" sort="Checkley, William" uniqKey="Checkley W" first="William" last="Checkley">William Checkley</name>
<affiliation>
<nlm:affiliation>Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cobb, Natalie" sort="Cobb, Natalie" uniqKey="Cobb N" first="Natalie" last="Cobb">Natalie Cobb</name>
<affiliation>
<nlm:affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington Medical Center, Seattle, Washington.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Maximous, Stephanie" sort="Maximous, Stephanie" uniqKey="Maximous S" first="Stephanie" last="Maximous">Stephanie Maximous</name>
<affiliation>
<nlm:affiliation>Division of Pulmonary Allergy Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Misango, David" sort="Misango, David" uniqKey="Misango D" first="David" last="Misango">David Misango</name>
<affiliation>
<nlm:affiliation>Department of Anaesthesiology and Critical Care Medicine, Aga Khan University Hospital, Nairobi, Kenya.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Park, Casey" sort="Park, Casey" uniqKey="Park C" first="Casey" last="Park">Casey Park</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Interdepartmental Division of Critical Care Medicine, Toronto, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Taran, Shaurya" sort="Taran, Shaurya" uniqKey="Taran S" first="Shaurya" last="Taran">Shaurya Taran</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Interdepartmental Division of Critical Care Medicine, Toronto, Canada.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lee, Burton W" sort="Lee, Burton W" uniqKey="Lee B" first="Burton W" last="Lee">Burton W. Lee</name>
<affiliation>
<nlm:affiliation>Division of Pulmonary Allergy Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="For The Covid Lmic Task Force And The Mahidol Oxford Research Unit Moru Bangkok Thailand" sort="For The Covid Lmic Task Force And The Mahidol Oxford Research Unit Moru Bangkok Thailand" uniqKey="For The Covid Lmic Task Force And The Mahidol Oxford Research Unit Moru Bangkok Thailand" last="For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand">For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand</name>
</author>
</analytic>
<series>
<title level="j">The American journal of tropical medicine and hygiene</title>
<idno type="eISSN">1476-1645</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The therapeutic options for COVID-19 patients are currently limited, but numerous randomized controlled trials are being completed, and many are on the way. For COVID-19 patients in low- and middle-income countries (LMICs), we recommend against using remdesivir outside of a clinical trial. We recommend against using hydroxychloroquine ± azithromycin or lopinavir-ritonavir. We suggest empiric antimicrobial treatment for likely coinfecting pathogens if an alternative infectious cause is likely. We suggest close monitoring without additional empiric antimicrobials if there are no clinical or laboratory signs of other infections. We recommend using oral or intravenous low-dose dexamethasone in adults with COVID-19 disease who require oxygen or mechanical ventilation. We recommend against using dexamethasone in patients with COVID-19 who do not require supplemental oxygen. We recommend using alternate equivalent doses of steroids in the event that dexamethasone is unavailable. We also recommend using low-dose corticosteroids in patients with refractory shock requiring vasopressor support. We recommend against the use of convalescent plasma and interleukin-6 inhibitors, such as tocilizumab, for the treatment of COVID-19 in LMICs outside of clinical trials.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">33377451</PMID>
<DateRevised>
<Year>2021</Year>
<Month>03</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1476-1645</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Dec</Month>
<Day>29</Day>
</PubDate>
</JournalIssue>
<Title>The American journal of tropical medicine and hygiene</Title>
<ISOAbbreviation>Am J Trop Med Hyg</ISOAbbreviation>
</Journal>
<ArticleTitle>Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.4269/ajtmh.20-1106</ELocationID>
<Abstract>
<AbstractText>The therapeutic options for COVID-19 patients are currently limited, but numerous randomized controlled trials are being completed, and many are on the way. For COVID-19 patients in low- and middle-income countries (LMICs), we recommend against using remdesivir outside of a clinical trial. We recommend against using hydroxychloroquine ± azithromycin or lopinavir-ritonavir. We suggest empiric antimicrobial treatment for likely coinfecting pathogens if an alternative infectious cause is likely. We suggest close monitoring without additional empiric antimicrobials if there are no clinical or laboratory signs of other infections. We recommend using oral or intravenous low-dose dexamethasone in adults with COVID-19 disease who require oxygen or mechanical ventilation. We recommend against using dexamethasone in patients with COVID-19 who do not require supplemental oxygen. We recommend using alternate equivalent doses of steroids in the event that dexamethasone is unavailable. We also recommend using low-dose corticosteroids in patients with refractory shock requiring vasopressor support. We recommend against the use of convalescent plasma and interleukin-6 inhibitors, such as tocilizumab, for the treatment of COVID-19 in LMICs outside of clinical trials.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shetty</LastName>
<ForeName>Varun U</ForeName>
<Initials>VU</Initials>
<AffiliationInfo>
<Affiliation>Critical Care Medicine Department, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Brotherton</LastName>
<ForeName>Brian Jason</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine, Kijabe Medical Center, Kijabe, Kenya.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Critical Care Medicine Department, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Achilleos</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Critical Care, Sunnybrook Health Sciences Center, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Akrami</LastName>
<ForeName>Kevan M</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Critical Care Medicine, University of California San Diego, San Diego, California.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Divisions of Infectious Disease, University of California San Diego, San Diego, California.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Barros</LastName>
<ForeName>Lia M</ForeName>
<Initials>LM</Initials>
<AffiliationInfo>
<Affiliation>Department of Cardiology, University of Washington Medical Center, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Checkley</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<AffiliationInfo>
<Affiliation>Center for Global Non-Communicable Disease Research and Training, School of Medicine, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Pulmonary and Critical Care, School of Medicine, Johns Hopkins University, Baltimore, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cobb</LastName>
<ForeName>Natalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington Medical Center, Seattle, Washington.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Maximous</LastName>
<ForeName>Stephanie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary Allergy Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Misango</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Anaesthesiology and Critical Care Medicine, Aga Khan University Hospital, Nairobi, Kenya.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Park</LastName>
<ForeName>Casey</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Interdepartmental Division of Critical Care Medicine, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Taran</LastName>
<ForeName>Shaurya</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Interdepartmental Division of Critical Care Medicine, Toronto, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Burton W</ForeName>
<Initials>BW</Initials>
<AffiliationInfo>
<Affiliation>Division of Pulmonary Allergy Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Critical Care Medicine Department, National Institutes of Health, Bethesda, Maryland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>For The Covid-Lmic Task Force And The Mahidol-Oxford Research Unit Moru Bangkok Thailand</LastName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>12</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Am J Trop Med Hyg</MedlineTA>
<NlmUniqueID>0370507</NlmUniqueID>
<ISSNLinking>0002-9637</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>12</Month>
<Day>30</Day>
<Hour>8</Hour>
<Minute>36</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>12</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>12</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33377451</ArticleId>
<ArticleId IdType="doi">10.4269/ajtmh.20-1106</ArticleId>
<ArticleId IdType="pmc">PMC7957231</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>JAMA Intern Med. 2019 Feb 1;179(2):213-223</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30575845</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2020 Oct 20;173(8):623-631</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32673060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2020 Oct 20;21(1):866</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33081849</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Dec 31;383(27):2598-2600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33264539</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 May 12;323(18):1824-1836</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Intern Med. 2017 Apr 1;177(4):554-560</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28192563</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2021 Feb 25;384(8):693-704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2020 Oct 20;21(1):867</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33081817</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2021 Feb 11;384(6):497-511</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33264556</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Sep 15;324(11):1048-1057</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32821939</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2020 Sep 1;130(9):4791-4797</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32525844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32401715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Heart Rhythm. 2020 Sep;17(9):1425-1433</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32407884</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2011 Feb 15;52(4):447-56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21248066</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2019 Dec 6;12:CD002243</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31808551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Intensive Care Med. 2020 May;46(5):854-887</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32222812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2020 Oct 13;21(1):846</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33050924</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Oct 5;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33031764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 Sep 4;370:m3379</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32887691</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2020 Jun;127:104388</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32361326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Dec 1;324(21):2165-2176</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33165621</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2015 Jan 1;211(1):80-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25030060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Transplant. 2020 Nov;20(11):3191-3197</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32476261</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Intensive Care. 2020 Jun 30;8:43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32612838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Oct 6;324(13):1307-1316</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32876695</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 May 14;369:m1844</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32409486</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Nov 5;383(19):1827-1837</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32459919</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Oct 6;324(13):1317-1329</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32876697</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Oct 6;324(13):1330-1341</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32876694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Rheumatol. 2020 Aug;2(8):e474-e484</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32835257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transfus Apher Sci. 2020 Oct;59(5):102875</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32694043</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2020 Jun 16;222(1):38-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32348485</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 2020 Jul;158(1):e9-e13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32243945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2004 Jul;10(7):676-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15214887</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008798</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32809882</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Dec 10;383(24):2333-2344</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33085857</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):589-596</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32417708</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2020 Aug 27;21(1):748</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32854751</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Respir Med. 2020 Mar;8(3):267-276</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32043986</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 22;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32450107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacotherapy. 2020 May;40(5):416-437</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32259313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2020 Aug 17;21(1):718</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32807209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Oct;92(10):1890-1901</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32293713</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32350134</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 2020 Aug;190(8):1680-1690</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32473109</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Nov 22;357(21):2189-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18032770</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32253318</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Autoimmun Rev. 2020 Jul;19(7):102554</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32380316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Dec 3;71(9):2459-2468</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32358954</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Intern Med. 2021 Feb 1;181(2):195-202</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33001138</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Oct 3;396(10256):959-967</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32896292</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2020 Jul 23;58(8):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32404482</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 Oct 22;371:m3939</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33093056</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Aug 4;324(5):460-470</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492084</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Oct 6;324(13):1298-1306</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32876689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Jun 13;395(10240):1820</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32511943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Nov 5;383(19):1813-1826</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32445440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trials. 2020 Aug 31;21(1):754</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32867852</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Cardiol. 2020 Sep 1;5(9):1036-1041</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32936252</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Drug Investig. 2020 Jun;40(6):511-518</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32337664</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000578 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000578 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33377451
   |texte=   Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33377451" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021